Compounding Pharmacy Says Summary Judgment Award In Semaglutide Spat Should Stand
TAMPA, Fla. — Novo Nordisk Inc. fails to “meet a high bar to alter or amend a judgment” under Federal Rule of Civil Procedure 59(e) for a Florida federal court to...To view the full article, register now.
Already a subscriber? Click here to view full article